Curr Cancer Drug Targets. 2025;25(2):144-158.doi: 10.2174/0115680096279597240219055135.
2025-05-07Curr Cancer Drug Targets. 2025;25(2):144-158.doi: 10.2174/0115680096279597240219055135. HAND2-AS1 Promotes Ferroptosis to Reverse Lenvatinib Resistance in Hepatocellular Carcinoma by TLR4/NOX2/DUOX2 Axis HAND2-AS1通过TLR4/NOX2/DUOX2轴促进肝细胞癌铁下垂以逆转乐伐替尼耐药性